Nomura Asset Management Co. Ltd. lowered its stake in Colgate-Palmolive Company (NYSE:CL) by 15.5% during the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 165,970 shares of the company’s stock after selling 30,352 shares during the period. Nomura Asset Management Co. Ltd.’s holdings in Colgate-Palmolive were worth $12,147,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Bank of New York Mellon Corp boosted its position in Colgate-Palmolive by 0.9% in the first quarter. Bank of New York Mellon Corp now owns 18,821,363 shares of the company’s stock valued at $1,377,537,000 after buying an additional 169,798 shares in the last quarter. First Eagle Investment Management LLC boosted its position in Colgate-Palmolive by 2.6% in the first quarter. First Eagle Investment Management LLC now owns 4,782,281 shares of the company’s stock valued at $350,015,000 after buying an additional 122,983 shares in the last quarter. TIAA CREF Investment Management LLC boosted its position in Colgate-Palmolive by 84.2% in the first quarter. TIAA CREF Investment Management LLC now owns 4,554,989 shares of the company’s stock valued at $333,380,000 after buying an additional 2,082,262 shares in the last quarter. Legal & General Group Plc boosted its position in Colgate-Palmolive by 5.1% in the first quarter. Legal & General Group Plc now owns 4,293,890 shares of the company’s stock valued at $314,276,000 after buying an additional 208,905 shares in the last quarter. Finally, Swiss National Bank boosted its position in Colgate-Palmolive by 22.2% in the first quarter. Swiss National Bank now owns 3,667,072 shares of the company’s stock valued at $268,393,000 after buying an additional 666,400 shares in the last quarter. 73.69% of the stock is owned by institutional investors and hedge funds.

Colgate-Palmolive Company (NYSE CL) traded down 0.39% during mid-day trading on Friday, reaching $71.02. The company’s stock had a trading volume of 3,317,565 shares. Colgate-Palmolive Company has a 52 week low of $63.43 and a 52 week high of $77.27. The firm has a 50-day moving average of $72.30 and a 200-day moving average of $72.91. The stock has a market capitalization of $62.56 billion, a price-to-earnings ratio of 26.39 and a beta of 0.80.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, July 21st. The company reported $0.72 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.72. Colgate-Palmolive had a return on equity of 3,121.95% and a net margin of 15.83%. The company had revenue of $3.83 billion during the quarter, compared to the consensus estimate of $3.89 billion. During the same period in the previous year, the firm posted $0.70 earnings per share. Colgate-Palmolive’s quarterly revenue was down .5% compared to the same quarter last year. On average, equities research analysts expect that Colgate-Palmolive Company will post $2.89 earnings per share for the current year.

The business also recently announced a quarterly dividend, which was paid on Tuesday, August 15th. Shareholders of record on Tuesday, July 18th were paid a $0.40 dividend. The ex-dividend date was Friday, July 14th. This represents a $1.60 dividend on an annualized basis and a yield of 2.25%. Colgate-Palmolive’s payout ratio is currently 59.48%.

COPYRIGHT VIOLATION WARNING: “Nomura Asset Management Co. Ltd. Has $12.15 Million Stake in Colgate-Palmolive Company (CL)” was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this article on another website, it was illegally stolen and republished in violation of U.S. and international copyright law. The legal version of this article can be viewed at https://www.thecerbatgem.com/2017/08/20/nomura-asset-management-co-ltd-has-12-15-million-stake-in-colgate-palmolive-company-cl.html.

CL has been the subject of several analyst reports. Bank of America Corporation upped their price objective on Colgate-Palmolive from $78.00 to $80.00 and gave the stock a “buy” rating in a research report on Wednesday, May 31st. Zacks Investment Research raised Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $83.00 target price for the company in a research report on Tuesday, July 4th. BidaskClub cut Colgate-Palmolive from a “hold” rating to a “sell” rating in a research report on Saturday, June 24th. Wells Fargo & Company reissued a “market perform” rating on shares of Colgate-Palmolive in a research report on Monday, July 24th. Finally, Royal Bank Of Canada reissued a “hold” rating and issued a $74.00 target price on shares of Colgate-Palmolive in a research report on Monday, April 24th. Two analysts have rated the stock with a sell rating, twelve have issued a hold rating and two have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of $75.82.

In other news, insider Patricia Verduin sold 3,833 shares of the business’s stock in a transaction that occurred on Thursday, June 15th. The stock was sold at an average price of $75.67, for a total transaction of $290,043.11. Following the completion of the transaction, the insider now directly owns 53,022 shares in the company, valued at $4,012,174.74. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, SVP John J. Huston sold 14,000 shares of the business’s stock in a transaction that occurred on Thursday, August 10th. The stock was sold at an average price of $71.36, for a total value of $999,040.00. Following the transaction, the senior vice president now owns 88,598 shares of the company’s stock, valued at $6,322,353.28. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 221,802 shares of company stock valued at $15,983,976. 1.02% of the stock is currently owned by insiders.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Stock Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related stocks with our FREE daily email newsletter.